Targeting GLP-1 receptors now has the FDA’s blessing as a way to treat the fatty liver disease called MASH with Novo Nordisk’s weekly injectable drug Wegovy becoming the second approved treatment for ...

Insecurity about transportation can lead to missed appointments and delayed care, and obstacles are more common for cancer ...

The healthcare industry is spending more than ever on AI — but according to executives from Oracle Health, HCA Healthcare and ...

AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are ...

The next phase of AI in healthcare is about building systems where human clinicians, supervisors, and AI can all contribute, ...

While the policy changes create new opportunities, they also introduce operational complexity. Here's some important things ...

By fine-tuning domain-specific models with real clinical operations data — such as historical performance, feasibility ...

The Digital Medicine Society launched an initiative to help payers and virtual care providers avoid common contract ...

CMS Administrator Dr. Mehmet Oz outlined the agency's strategy for making healthcare more affordable during a Tuesday address ...

Healthcare affordability czar Casey Mulligan laid out the economic philosophy guiding the Trump administration's approach to ...

Clinical AI startup Abridge held a New York City event to signal it's done being thought of as just an AI scribe. The company announced a Nvidia foundation model partnership, an Eli Lilly investment, ...

The true promise of AI lies not in autonomy of either the clinician or machine, but in a balanced collaboration that bolsters ...